pcDNA3.1-(-)-Pur Citations (4)

Originally described in: Eukaryotic expression plasmid with a puromycin selection marker
Unpublished

---

Articles Citing pcDNA3.1-(-)-Pur

Articles
LncRNA TYMSOS facilitates breast cancer metastasis and immune escape through downregulating ULBP3. Zhang KJ, Tan XL, Guo L. iScience. 2023 Aug 7;26(9):107556. doi: 10.1016/j.isci.2023.107556. eCollection 2023 Sep 15. PubMed
De novo steroidogenesis in tumor cells drives bone metastasis and osteoclastogenesis. Sandor LF, Huh JB, Benko P, Hiraga T, Poliska S, Dobo-Nagy C, Simpson JP, Homer NZM, Mahata B, Gyori DS. Cell Rep. 2024 Mar 26;43(3):113936. doi: 10.1016/j.celrep.2024.113936. Epub 2024 Mar 13. PubMed
BCL-XL Protects ASS1-Deficient Cancers from Arginine Starvation-Induced Apoptosis. Panda PK, Paschoalini Mafra AC, Bastos ACS, Cao L, Serra Bonet M, Brashears CB, Chen EY, Benedict-Hamilton HM, Ehrhardt W, Bomalaski J, Dehner C, Rogers LC, Oyama T, Van Tine BA. Clin Cancer Res. 2025 Apr 1;31(7):1333-1345. doi: 10.1158/1078-0432.CCR-24-2548. PubMed
tRF-21LeuTAA Promotes Oxidative Stress by Altering Glutathione Metabolic Enzymes to Support Prostate Cancer Progression. Guo X, Zhong J, Qian J, Pan X, Zhang X, Chen X, Zeng H, Chen N, Nie L, Yu T, Zhou Q. Cancer Res. 2025 Dec 1;85(23):4787-4805. doi: 10.1158/0008-5472.CAN-25-0273. PubMed

If you have published an article using this material, please email us at to have your article added to this page.